Hidenori Toyoda

Hidenori Toyoda

UNVERIFIED PROFILE

Are you Hidenori Toyoda?   Register this Author

Register author
Hidenori Toyoda

Hidenori Toyoda

Publications by authors named "Hidenori Toyoda"

Are you Hidenori Toyoda?   Register this Author

100Publications

2369Reads

21Profile Views

Natural history of liver-related disease in patients with chronic hepatitis C virus infection: An analysis using a Markov chain model.

J Med Virol 2019 Oct 16;91(10):1837-1844. Epub 2019 Jul 16.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmv.25533DOI Listing
October 2019

The course of elderly patients with persistent hepatitis C virus infection without hepatocellular carcinoma.

J Gastroenterol 2019 Sep 3;54(9):829-836. Epub 2019 Jun 3.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-019-01595-5DOI Listing
September 2019

Serum Nutritional Markers as Prognostic Factors for Hepatic and Extrahepatic Carcinogenesis in Japanese Patients with Nonalcoholic Fatty Liver Disease.

Nutr Cancer 2019 Aug 21:1-8. Epub 2019 Aug 21.

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine , Nagoya , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2019.1653474DOI Listing
August 2019

Long-term prognosis of liver disease in patients with chronic hepatitis B virus infection receiving nucleos(t)ide analogue therapy: an analysis using a Markov chain model.

Eur J Gastroenterol Hepatol 2019 May 6. Epub 2019 May 6.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MEG.0000000000001434DOI Listing
May 2019

Type 2 diabetes mellitus: A risk factor for progression of liver fibrosis in middle-aged patients with non-alcoholic fatty liver disease.

J Gastroenterol Hepatol 2019 May 21. Epub 2019 May 21.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/jgh.14734
Publisher Site
http://dx.doi.org/10.1111/jgh.14734DOI Listing
May 2019

Direct-acting antiviral therapy for chronic hepatitis C virus genotype 4 infection: Exploring new regimens.

Authors:
Hidenori Toyoda

Health Sci Rep 2019 Mar 4;2(3):e106. Epub 2019 Mar 4.

Department of Gastroenterology Ogaki Municipal Hospital Ogaki Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hsr2.106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6427055PMC
March 2019

Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients.

J Gastroenterol Hepatol 2019 Jan 18;34(1):207-214. Epub 2018 Sep 18.

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14448DOI Listing
January 2019

Impact of hepatocellular carcinoma aetiology and liver function on the benefit of surveillance: A novel approach for the adjustment of lead-time bias.

Liver Int 2018 12 30;38(12):2260-2268. Epub 2018 Jul 30.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13927DOI Listing
December 2018

Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model.

J Gastroenterol 2018 Nov 19;53(11):1196-1205. Epub 2018 Apr 19.

Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-018-1467-xDOI Listing
November 2018

Substitutions in interferon sensitivity-determining region and hepatocarcinogenesis after hepatitis C virus eradication.

J Gastroenterol Hepatol 2018 Nov 3;33(11):1904-1911. Epub 2018 Jun 3.

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14280DOI Listing
November 2018

A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.

Clin Chim Acta 2018 Oct 15;485:187-194. Epub 2018 Jun 15.

Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China; Precision Medical Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2018.06.020DOI Listing
October 2018

New scoring system combining the FIB-4 index and cytokeratin-18 fragments for predicting steatohepatitis and liver fibrosis in patients with nonalcoholic fatty liver disease.

Biomarkers 2018 May - Jun;23(4):328-334. Epub 2018 Jan 19.

c Department of Diagnostic Pathology , Kurume University Hospital , Kurume, Fukuoka , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1354750X.2018.1425915DOI Listing
September 2018

Impact of previously cured hepatocellular carcinoma (HCC) on new development of HCC after eradication of hepatitis C infection with non-interferon-based treatments.

Aliment Pharmacol Ther 2018 Sep 25;48(6):664-670. Epub 2018 Jul 25.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.14914DOI Listing
September 2018

Significance of day-1 viral response of hepatitis C virus in patients with chronic hepatitis C receiving direct-acting antiviral therapy.

J Gastroenterol Hepatol 2018 Jun 23;33(6):1264-1270. Epub 2018 Feb 23.

Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.14053DOI Listing
June 2018

Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers.

J Gastroenterol Hepatol 2018 Apr 26;33(4):918-925. Epub 2018 Jan 26.

Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.13989DOI Listing
April 2018

Imaging basis of AFP and WFAM2BP as indicators of the risk of HCC after SVR.

J Hepatol 2018 03 25;68(3):606-607. Epub 2017 Oct 25.

Department of Gastroenterology, Ogaki Municipal Hospital, Japan.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01688278173238
Publisher Site
http://dx.doi.org/10.1016/j.jhep.2017.08.040DOI Listing
March 2018

Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment.

Hepatol Int 2018 Mar 29;12(2):133-142. Epub 2018 Mar 29.

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12072-018-9859-9DOI Listing
March 2018

Differences in the impact of prognostic factors for hepatocellular carcinoma over time.

Cancer Sci 2017 Dec 20;108(12):2438-2444. Epub 2017 Oct 20.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.13406DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715354PMC
December 2017

Progression of liver fibrosis is associated with non-liver-related mortality in patients with nonalcoholic fatty liver disease.

Hepatol Commun 2017 11 26;1(9):899-910. Epub 2017 Sep 26.

Department of Epidemiology Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences Hiroshima Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep4.1105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721461PMC
November 2017

Post-treatment levels of α-fetoprotein predict long-term hepatocellular carcinoma development after sustained virological response in patients with hepatitis C.

Hepatol Res 2017 Sep 19;47(10):1021-1031. Epub 2016 Dec 19.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12839DOI Listing
September 2017

Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.

Liver Int 2017 08 29;37(8):1138-1147. Epub 2017 Jan 29.

Departments of Virology & Liver unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/liv.13349
Publisher Site
http://dx.doi.org/10.1111/liv.13349DOI Listing
August 2017

Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan.

PLoS One 2016 9;11(6):e0157103. Epub 2016 Jun 9.

Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung, Taiwan.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0157103PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900519PMC
July 2017

Reply to: "HBV markers for HCC prediction: Three heads are better than two?"

J Hepatol 2017 07 1;67(1):204-205. Epub 2017 Apr 1.

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2017.03.025DOI Listing
July 2017

Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.

Biochim Biophys Acta Mol Basis Dis 2017 06 26;1863(6):1629-1639. Epub 2017 Apr 26.

Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2017.04.021DOI Listing
June 2017

Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.

J Gastroenterol Hepatol 2017 Mar;32(3):687-694

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.13589DOI Listing
March 2017

Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.

J Gastroenterol Hepatol 2017 Feb;32(2):451-458

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jgh.13473DOI Listing
February 2017

Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.

Br J Cancer 2017 Feb 12;116(4):441-447. Epub 2017 Jan 12.

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, 4-86 Minaminokawa-cho, Ogaki, Gifu 503-8052, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318967PMC
February 2017

Changes in patient backgrounds may increase the incidence of HCC after SVR in the era of IFN-free therapy for HCV.

Hepatology 2016 11 7;64(5):1818-1819. Epub 2016 Jun 7.

Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep.28632DOI Listing
November 2016

Reply to: Comment on: 'Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'.

Br J Cancer 2016 08 23;115(5):e6. Epub 2016 Jun 23.

Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, 4-86 Minaminokawa-cho, Ogaki, Gifu 503-8052, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2016.197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4997541PMC
August 2016

Extra-hepatic feeding arteries of hepatocellular carcinoma: An investigation based on intra-arterial CT aortography images using an angio-MDCT system.

Eur J Radiol 2016 Aug 17;85(8):1400-6. Epub 2016 May 17.

Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2016.05.007DOI Listing
August 2016

Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma.

J Gastroenterol Hepatol 2016 Jul;31(7):1300-6

Department of Clinical Oncology, State Key Laboratory in Oncology in South China, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong kong.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/jgh.13291
Publisher Site
http://dx.doi.org/10.1111/jgh.13291DOI Listing
July 2016

Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.

J Gastroenterol 2016 Jul 12;51(7):741-7. Epub 2016 Feb 12.

Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Science, Nagoya, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-016-1174-4DOI Listing
July 2016

HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics.

J Hepatol 2016 07 29;65(1):48-56. Epub 2016 Mar 29.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.03.013DOI Listing
July 2016

Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients.

Clin Gastroenterol Hepatol 2016 06 13;14(6):875-886.e6. Epub 2016 Jan 13.

Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom; The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.12.042DOI Listing
June 2016

Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection: a propensity score analysis.

Liver Int 2016 06 12;36(6):817-26. Epub 2016 Feb 12.

Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13071DOI Listing
June 2016

Response to 'WFA(+)-M2BP: a novel biomarker with diagnostic and therapeutic implications in liver diseases'.

Liver Int 2016 Apr;36(4):613

Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/liv.13044DOI Listing
April 2016

Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.

Ultrasound Med Biol 2015 Dec 7;41(12):3070-8. Epub 2015 Sep 7.

Department of Imaging Diagnosis, Ogaki Municipal Hospital, Ogaki, Gifu, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ultrasmedbio.2015.07.023DOI Listing
December 2015

[Hepatitis B virus infection and its prevention].

Nihon Rinsho 2015 Dec;73 Suppl 9:565-9

View Article

Download full-text PDF

Source
December 2015